Jeffrey A. Medin, PhD, named MACC Fund Endowed Professor
We are very pleased to announce the appointment of Jeffrey A. Medin, PhD, as the MACC Fund Professor in the Department of Pediatrics at the Medical College of Wisconsin (MCW). Dr. Medin has a distinguished record of accomplishment in the field of pediatric cancers, and our research and clinical partners at the MACC Fund and Children’s Hospital of Wisconsin (Children’s) joined us as active participants in this crucial recruitment.
Dr. Medin’s appointment as the MACC Fund Professor represents the importance of fighting cancer as a strategic priority of MCW, and highlights how we work closely with our partners at the MACC Fund and Children’s to improve outcomes for children and families during some of the toughest moments of their lives. Founded in 1976 by former Milwaukee Buck Jon McGlocklin and Bucks announcer Eddie Doucette (whose then two-year old son had been diagnosed with cancer), the MACC Fund is the single largest private donor to MCW and the largest organizational donor to Children’s Hospital of Wisconsin – having provided a total of more than $45 million in support of basic science and clinical trials, as well as bringing research more quickly to the bedside and patient care. As a result of this exceptional generosity, Children’s named its pediatric oncology program the “MACC Fund Center” in 2013. Support from the MACC Fund also played a significant role in Children’s becoming the only designated Phase 1 Center for clinical trials in the state undertaken by the Children’s Oncology Group, and one of only 21 nationwide.
The MACC Fund established The MACC Fund Chair to recruit a distinguished researcher to MCW who would encourage the growth of our basic science investigations and further develop our translational research efforts with Children’s. Dr. Medin’s background as a research innovator and scientific leader make him uniquely well qualified to serve at the first MACC Fund Professor.
At MCW, Dr. Medin also will hold the titles of Vice Chair of Research Innovation for the Department of Pediatrics, and Research Director within the Section of Pediatric Hematology/Oncology – where he is expected to expand the Pediatric Hematology-Oncology-Transplant program. Further, Dr. Medin will serve as Director, Cell Processing Laboratories, Medical College of Wisconsin Adult and Pediatric Blood and Marrow Transplant Program. Dr. Medin also will hold appointments in the MCW Cancer Center and the Blood Research Center. Additionally, Dr. Medin will be the Good Manufacturing Practice (GMP) Facility Director. MCW is committed to building a state-of-the-art GMP facility (to serve as a campus-wide core), as cellular therapy is a priority for both the Department of Pediatrics and the MCW Cancer Center. Dr. Medin will assume his full duties on January 1, 2016.
Dr. Medin received a Bachelor of Science degree from the University of Wisconsin-Parkside in 1985. In 1991, he received a PhD in Biochemistry from the University of Kentucky, where he studied protein expression and enzymology. Dr. Medin was employed with the National Institutes of Health from 1992-1998, in the following roles: National Research Council Biotech Fellow with the Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development (1992-1993); Intramural Research Fellow with the Molecular and Medical Genetics Section, Development and Metabolic Neurology Branch (DMNB), National Institute of Neurological Disorders and Stroke (NINDS) (1994-1996); and Senior Staff Fellow in the DMNB, NINDS (1996-1998). Among Dr. Medin’s areas of research at the NIH were gene transcription, Lysosomal Storage Disorders, and gene therapy.
From 1998-2001, Dr. Medin was Assistant Professor of Medicine and an Affiliate Member of the Department of Biochemistry and Molecular Biology at the University of Illinois at Chicago. Dr. Medin relocated to Toronto in 2001, where he held the following appointments: Scientist, Ontario Cancer Institute, Division of Stem Cell and Developmental Biology (2001-2006); Associate Professor, Department of Medical Biophysics, Faculty of Medicine, University of Toronto (2001-2008); Affiliated Scientists, Division of Experimental Therapeutics, Toronto General Research Institute (2001-2012); and Senior Scientist, Ontario Cancer Institute (2006-2012).
Dr. Medin’s laboratory currently focuses on the development and implementation of gene therapy using integrating viral vectors for inherited and acquired disorders. Dr. Medin has applied for 20 patents since
2001 and has co-registered 16 inventions during the past decade.
Dr. Medin has significant teaching experience as a lecturer, course coordinator and section leader, and is a member of the Curriculum Committee of the Department of Medical Biophysics at the University of Toronto. He has been a member of numerous American and Canadian scientific societies and advisory committees in areas such as Biochemistry, Gene Therapy, Molecular and Cellular Biology, Prostate Cancer, Breast Cancer, and Hematology. Additionally, Dr. Medin is an Academic Founder and member of the Scientific Advisory Board (SAB) of AvroBio LTD. He also is a member of the SAB of Plexera Therapeutics and an editorial board member of the World Journal of Stem Cells and Biomedicines. Dr. Medin has published more than 100 peer-reviewed papers, edited an immunotherapy book, and presented at more than 100 invited conferences and workshops.
We plan to work closely with Children’s and the MACC Fund to provide Dr. Medin with a generous introduction to the community. Please join us in welcoming Dr. Medin to MCW.
Medical College of Wisconsin
Department of Pediatrics
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 955-4170 | (414) 955-6543 (fax)
Pediatric Hematology Clinic
Pediatric Oncology Clinic
Pediatric BMT Clinic
Pediatrics Hematology/Oncology/BMT Site Map